Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 310 Results
Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022
February 10, 2022
Palatin to Present at H.C. Wainwright BioConnect Conference
January 7, 2022
Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease
December 28, 2021
Notice of Allowance Issued for Method of Treating Cytokine Storm Using Melanocortin-Specific Peptide
November 30, 2021
Palatin Reports First Quarter Fiscal Year 2022 Results and Provides Corporate Update
November 15, 2021
Palatin to Report First Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on November 15, 2021
November 10, 2021
Palatin Awarded “Top 10 Poster” Designation at the American Society of Retina Specialists (ASRS) 2021 Annual Meeting
October 22, 2021